ASCP 2023: A Phase 1 SAD and MAD Trial of EVX-101, a Novel Gastro-Retentive Prolonged Release
9 October 2023
Overview
Presented at ASCP 2023, "A Phase 1 SAD and MAD Trial of EVX-101, a Novel Gastro-Retentive Prolonged Release". Find out about how Quotient Sciences can help accelerate your drug development program.